JP Patent

JP7161731B2 — 疾患及び障害の処置及び予防のための短鎖脂肪酸の使用

Assigned to Temple Univ School of Medicine · Expires 2022-10-27 · 4y expired

What this patent protects

Patent listed against Otezla.

Drugs covered by this patent

Patent Metadata

Patent number
JP7161731B2
Jurisdiction
JP
Classification
—
Expires
2022-10-27
Drug substance claim
No
Drug product claim
No
Assignee
Temple Univ School of Medicine
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.